COP vs MTNB · P/E 19, rev $58.94B vs rev $1.1M
ConocoPhillips (COP) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the COP and MTNB stock pages for the full models.
Not investment advice.